Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy

Epilepsy Research
Salvatore StrianoFrancesco Pisani

Abstract

To investigate the relationship between the serum concentration of the mono-hydroxy-derivative (MHD) of oxcarbazepine (OXC) and adverse effects (AEs) in epileptic patients on high-dose OXC therapy. Forty-four consecutive patients, aged 18-65 years, with refractory epilepsy receiving OXC dosages > or = 1500 mg/day (range 1500-3300 mg/day) were assessed at an outpatient clinic. Serum MHD concentrations were determined by a specific HPLC assay in samples collected before the morning dose and 2 h after drug intake. An independent observer assessed AEs at each sampling time. AEs were reported in five patients at the first sampling time, and in 26 patients at the second sampling time. Nystagmus, sedation, blurred vision, and dizziness were the most frequent AEs. MHD concentrations (means +/- S.D.) associated with AEs were 29.6 +/- 5.58 compared with 21.7 +/- 5.0 mg/L when no AEs were detected (p = 0.0001). AEs were minimized in most patients by reducing OXC dose, increasing the number of daily administrations, or both. Patients with serum MHD concentrations > or = 30 mg/L are at greater risk of developing AEs. In many patients, AEs occur intermittently in relation to fluctuations in serum MHD. Monitoring MHD concentrations could help...Continue Reading

References

Feb 9, 2000·European Journal of Clinical Pharmacology·T Tomson, S I Johannessen
Apr 5, 2000·Clinical Pharmacokinetics·E Perucca
Nov 2, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·P M EdelbroekH H Geesink
May 15, 2002·Journal of Pharmaceutical and Biomedical Analysis·H LevertH Robert
May 27, 2003·Therapeutic Drug Monitoring·Svein I JohannessenPhilip N Patsalos
Aug 2, 2003·Clinical Pharmacology and Therapeutics·William M SallasMohammad Hossain
Sep 10, 2003·Clinical Pharmacokinetics·Theodor W MayBernhard Rambeck
Jan 21, 2004·CNS Drugs·Lynne M Bang, Karen L Goa
Dec 29, 2005·Neurology·Xiaoming DongJohn Rarick

❮ Previous
Next ❯

Citations

Feb 2, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ivan AdamecMario Habek
Nov 26, 2008·Clinical Pharmacokinetics·Penny Bring, Mary H H Ensom
Nov 1, 2011·Drugs·Cinzia Fattore, Emilio Perucca
Nov 15, 2013·Epilepsy Research·Alberto VerrottiGaetano Zaccara
Jun 19, 2014·Expert Opinion on Pharmacotherapy·Lorenza ChiossiPaolo Martelletti
Sep 13, 2015·Seizure : the Journal of the British Epilepsy Association·Annika SattlerTheodor W May
Mar 9, 2010·Thérapie·Régis BouquiéUNKNOWN le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
Mar 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Lia SantulliSalvatore Striano
Jun 29, 2016·Neurología : publicación oficial de la Sociedad Española de Neurología·V VillanuevaC Viteri
Nov 5, 2016·Journal of Critical Care·Keaton S SmetanaDouglas R Oyler
Jul 23, 2016·Acta Neurologica Scandinavica·E SchmidE Trinka
Jul 20, 2010·Pharmaceuticals·Matthew D Krasowski
Jul 25, 2017·European Neurology·Irina ConstantinescuMargitta Seeck
Sep 1, 2018·Expert Opinion on Drug Safety·Romina MoaveroPaolo Curatolo
Aug 5, 2017·British Journal of Clinical Pharmacology·Christelle RodriguesVincent Jullien
Nov 30, 2018·Expert Opinion on Pharmacotherapy·Monika BanachStanisław J Czuczwar
Mar 16, 2017·Brain and Behavior·Jussi MäkinenJukka Peltola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.